Overall, in the primary analysis, there was high heterogeneity (I2 = 70.4%, p ≤ 0.001), and GR expression was not associated with cancer survival pooling estimates from univariate analysis (HR = 1.16, 95% CI (0.89, 1.50)) (Figure 3). The gene discussed is NR3C1; the disease is cancer.